Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-08

Clinical Trial Update: Ursodiol on Insulin Sensitivity, Gastric Emptying and Body Weight With Type 2 Diabetes on Metformin [Phase 2]

View source ↗

Summary

Phase 2 clinical trial examining the effects of Ursodiol on insulin sensitivity, gastric emptying, and body weight in adults with Type 2 Diabetes Mellitus on me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • URSODIOL (ursodiol)

Snippet

Sponsor: Mayo Clinic | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2019-05-08